Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Damage | 11 | 2017 | 352 | 1.810 |
Why?
|
| DNA, Mitochondrial | 7 | 2017 | 175 | 1.260 |
Why?
|
| DNA Repair | 10 | 2017 | 188 | 1.250 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 6 | 2017 | 16 | 0.870 |
Why?
|
| Saccharomyces cerevisiae | 7 | 2009 | 206 | 0.820 |
Why?
|
| Saccharomyces cerevisiae Proteins | 6 | 2009 | 118 | 0.690 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2014 | 234 | 0.540 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 111 | 0.430 |
Why?
|
| DNA Repair Enzymes | 3 | 2009 | 20 | 0.400 |
Why?
|
| Endodeoxyribonucleases | 3 | 2009 | 29 | 0.400 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 441 | 0.400 |
Why?
|
| DNA, Fungal | 3 | 2009 | 46 | 0.370 |
Why?
|
| Ultraviolet Rays | 4 | 2004 | 117 | 0.280 |
Why?
|
| Fungal Proteins | 3 | 2002 | 140 | 0.250 |
Why?
|
| Mitochondria | 3 | 2014 | 487 | 0.240 |
Why?
|
| DNA Replication | 4 | 2004 | 152 | 0.230 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2004 | 43 | 0.200 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 82 | 0.200 |
Why?
|
| Huntington Disease | 2 | 2012 | 27 | 0.190 |
Why?
|
| Gene Deletion | 3 | 2009 | 166 | 0.170 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 617 | 0.160 |
Why?
|
| DNA Polymerase III | 1 | 1997 | 10 | 0.150 |
Why?
|
| Azoxymethane | 1 | 2017 | 7 | 0.150 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 12 | 0.150 |
Why?
|
| Ligases | 1 | 1996 | 6 | 0.140 |
Why?
|
| Carcinogens | 1 | 2017 | 124 | 0.140 |
Why?
|
| Enzyme Activators | 1 | 2015 | 12 | 0.130 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 14 | 0.130 |
Why?
|
| Cyclophilins | 1 | 2015 | 9 | 0.130 |
Why?
|
| PPAR alpha | 1 | 2015 | 42 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 1371 | 0.120 |
Why?
|
| Metformin | 1 | 2015 | 65 | 0.120 |
Why?
|
| DNA | 3 | 2011 | 574 | 0.120 |
Why?
|
| Mice | 7 | 2017 | 5913 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 166 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 155 | 0.110 |
Why?
|
| Neostriatum | 1 | 2012 | 26 | 0.110 |
Why?
|
| Epistasis, Genetic | 3 | 2004 | 16 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 251 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 448 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2015 | 938 | 0.100 |
Why?
|
| Antioxidants | 1 | 2015 | 416 | 0.100 |
Why?
|
| Spermatogenesis | 1 | 2011 | 155 | 0.090 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2002 | 22 | 0.090 |
Why?
|
| Carbon-Oxygen Lyases | 2 | 2000 | 4 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2011 | 200 | 0.090 |
Why?
|
| Alkylation | 1 | 2009 | 11 | 0.090 |
Why?
|
| Animals | 8 | 2017 | 15081 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1997 | 188 | 0.080 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 461 | 0.080 |
Why?
|
| Kinetics | 1 | 2009 | 708 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2011 | 89 | 0.070 |
Why?
|
| DNA-Directed DNA Polymerase | 2 | 2004 | 23 | 0.070 |
Why?
|
| Humans | 6 | 2017 | 37093 | 0.060 |
Why?
|
| alpha-Fetoproteins | 3 | 1995 | 31 | 0.060 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 539 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 2012 | 366 | 0.060 |
Why?
|
| Endonucleases | 1 | 2004 | 20 | 0.060 |
Why?
|
| SUMO-1 Protein | 1 | 2004 | 10 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2004 | 78 | 0.060 |
Why?
|
| Deoxyribonuclease IV (Phage T4-Induced) | 2 | 2000 | 2 | 0.060 |
Why?
|
| Middle Aged | 2 | 2014 | 10129 | 0.060 |
Why?
|
| Male | 5 | 2014 | 20025 | 0.050 |
Why?
|
| Aged | 1 | 2014 | 6741 | 0.050 |
Why?
|
| Templates, Genetic | 1 | 2002 | 25 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 36 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 167 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2002 | 41 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2004 | 15 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 75 | 0.050 |
Why?
|
| Mutation | 4 | 2012 | 1095 | 0.050 |
Why?
|
| Methyl Methanesulfonate | 1 | 2000 | 6 | 0.050 |
Why?
|
| Alkylating Agents | 1 | 2000 | 13 | 0.050 |
Why?
|
| Mutagens | 1 | 2000 | 69 | 0.040 |
Why?
|
| Female | 3 | 2014 | 20969 | 0.040 |
Why?
|
| Plasmids | 2 | 1996 | 246 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 2012 | 190 | 0.040 |
Why?
|
| Radiation Tolerance | 1 | 1996 | 12 | 0.040 |
Why?
|
| G2 Phase | 1 | 1996 | 29 | 0.040 |
Why?
|
| S Phase | 1 | 1996 | 37 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 1995 | 2 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 1995 | 3 | 0.030 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1995 | 4 | 0.030 |
Why?
|
| Liver Diseases | 1 | 1995 | 33 | 0.030 |
Why?
|
| Pyrones | 1 | 2015 | 9 | 0.030 |
Why?
|
| Tyrosine | 1 | 1995 | 118 | 0.030 |
Why?
|
| Oxidants | 1 | 2015 | 45 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 1568 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2015 | 53 | 0.030 |
Why?
|
| Thiophenes | 1 | 2015 | 31 | 0.030 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2015 | 33 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 84 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2015 | 66 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 122 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 1994 | 86 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 267 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 444 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 433 | 0.030 |
Why?
|
| Liver | 2 | 1995 | 479 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 674 | 0.030 |
Why?
|
| Autopsy | 1 | 2012 | 43 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 62 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 610 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1039 | 0.030 |
Why?
|
| Base Sequence | 3 | 2004 | 997 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 972 | 0.020 |
Why?
|
| Heterozygote | 1 | 2011 | 93 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 1354 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1130 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 431 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 272 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 360 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1742 | 0.020 |
Why?
|
| Propionates | 1 | 2008 | 26 | 0.020 |
Why?
|
| Guanosine | 1 | 2008 | 27 | 0.020 |
Why?
|
| Nitro Compounds | 1 | 2008 | 33 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2008 | 1609 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 923 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1033 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3483 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 290 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 2721 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 1908 | 0.020 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 2004 | 4 | 0.020 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 2004 | 9 | 0.020 |
Why?
|
| Glycolates | 1 | 2004 | 6 | 0.020 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2004 | 11 | 0.020 |
Why?
|
| Transglutaminases | 1 | 2004 | 8 | 0.020 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2004 | 2 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 2004 | 38 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1398 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1994 | 24 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 677 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1995 | 1207 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1994 | 1518 | 0.010 |
Why?
|
| Genes, rev | 1 | 1998 | 2 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 11712 | 0.010 |
Why?
|
| Heptanoates | 1 | 1995 | 1 | 0.010 |
Why?
|
| Hydrolases | 1 | 1995 | 15 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 1180 | 0.010 |
Why?
|
| Pancreas | 1 | 1995 | 35 | 0.010 |
Why?
|
| Amino Acids | 1 | 1995 | 145 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1994 | 84 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1994 | 45 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1994 | 136 | 0.010 |
Why?
|
| Fetus | 1 | 1994 | 105 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1994 | 343 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 502 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1995 | 190 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 1992 | 18 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1992 | 25 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1994 | 435 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1994 | 515 | 0.010 |
Why?
|
| Transfection | 1 | 1992 | 523 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1992 | 307 | 0.010 |
Why?
|
| Kidney | 1 | 1992 | 337 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1992 | 681 | 0.000 |
Why?
|
| Brain | 1 | 1992 | 1346 | 0.000 |
Why?
|